These three use cases reflect different biological contexts and different expected time horizons for response
The recommended starting dosage of injectable semaglutide for facilitating weight loss is as follows: Weeks 1 through 4: 0.25 mg subcutaneously once a week Weeks 5 through 8: 0.5 mg subcutaneously once a week Weeks 9 through 12: 1 mg subcutaneously once a week Weeks 13 through 16: 1.7 mg subcutaneously once a week Maintenance dose: 2.4 mg subcutaneously once a week from week 17 onwards
Fatigue may result from multiple factors including significant caloric deficit from appetite suppression, metabolic adaptation to weight loss, nutritional deficiencies, gastrointestinal side effects affecting food and fluid intake, and changes in blood glucose levels
However, your dosage may vary based on your doctors recommendation and on whether they choose to prescribe one of the other brand-name drugs off-label
Tirzepatide starts at 2.5mg weekly with a 4-week escalation plan, reaching 5mg, 10mg, or 15mg maintenance doses depending on tolerance and results
